ARCHIVES

RFA Available

This article is from The Cancer Letter archive.

Vol. 25 No. 02 | January 15, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

FDA to refer false statements by regulated companies to SEC.

February 27, 2004

Supreme Court Lets Stand Lower Court Ruling On AZT Patents

January 19, 1996

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

November 5, 2004

Hawaii Gets CBCCP Award

August 12, 1977

Congress Approves More Favorable Terms for Office-Administered Drugs

August 8, 1997